Skip to content

Septerna, Inc. SEPN Operating lease liabilities

Operating lease liabilities at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
Precigen logo
PrecigenPGEN
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
Arrowhead Research logo
Arrowhead ResearchARWR
Enliven Therapeutics logo
Enliven TherapeuticsELVN

Other financials

Income statement

See full
Revenue$26.5M+12,011%
Operating income-$13.3M+48.7%
Net income-$8.6M+59.8%
EPS (diluted)-$0.19+61.2%

Balance sheet

See full
Cash & equivalents$71.6M-65.9%
Total debt$23.1M-7.7%
Total equity$378.5M+195%
Total assets$569.7M+31.3%

Cash flow

See full
Operating cash flow-$25.6M-9.8%
CapEx$832.0K+118%
Free cash flow-$26.5M-11.5%

Valuation

See full
Market cap$1.62B+319%

Profitability

See full
Operating margin-77.1%-38.4pp
Net margin-49.9%-24.9pp
FCF margin467.9%+243pp

Returns & leverage

See full
Return on equity-12.2%
Debt / equity0.1×
Current ratio4.7×-27.5×

Where this comes from

Reported directly by Septerna, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Septerna, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Septerna, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Septerna, Inc.'s operating lease liabilities?
Septerna, Inc. (SEPN) reported operating lease liabilities of -$535K in Q1 2026.
How has Septerna, Inc.'s operating lease liabilities changed year-over-year?
Septerna, Inc.'s operating lease liabilities decreased by 18.9% year-over-year, from -$450K to -$535K.